Role of CXCR4 Chemokine Receptor Blockade Using AMD3100 for Mobilization of Autologous Hematopoietic Progenitor Cells
- 1 November 2005
- journal article
- review article
- Published by S. Karger AG in Acta Haematologica
- Vol. 114 (4) , 198-205
- https://doi.org/10.1159/000088410
Abstract
G-CSF mobilization of hematopoietic progenitor cells (HPCs) is mediated through enzyme release from maturing myeloid cells, leading to digestion of adhesion molecules, trophic chemokines and their receptors, and the extracellular matrix. HPCs traffic to and are retained in the marrow through the trophic effects of the chemokine SDF-1alpha/CXCL12 binding to its receptor, CXCR4. AMD3100 reversibly inhibits SDF-1alpha/CXCR4 binding, and AMD3100 administration mobilizes CD34+ cells into the circulation. AMD3100 has been tested in several clinical trials which demonstrate that it improves the number of CD34+ cells mobilized including patients failing to mobilize with G-CSF alone. Engraftment of AMD3100-mobilized cells is prompt and durable. Toxicities are mild and infrequent. Lymphoma and myeloma cells do not appear to be mobilized. AMD3100 appears to be a promising agent for HPC mobilization.Keywords
This publication has 48 references indexed in Scilit:
- Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonistTransfusion, 2005
- Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistBlood, 2003
- High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemiaTransplantation and Cellular Therapy, 2003
- The role of G-protein signaling in hematopoietic stem/progenitor cell mobilizationBlood, 2003
- Current understanding of stem cell mobilizationExperimental Hematology, 2002
- Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4Journal of Biological Chemistry, 2002
- Autologous peripheral blood progenitor cell transplantation with <2×106 CD34+/kg: an analysis of variables concerning mobilisation and engraftmentThe Hematology Journal, 2000
- ChemokinesImmunity, 2000
- Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 1999
- Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet RecoveryJournal of Hematotherapy, 1996